BRIACELL THERAPEUTICS CORP. Unrealized Gain (Loss) on Investments
BRIACELL THERAPEUTICS CORP. (BCTX) reported Unrealized Gain (Loss) on Investments of $137.83 thousand for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-06-09
- BRIACELL THERAPEUTICS CORP. unrealized gain (loss) on investments for the quarter ending 2026-04-30 was $137.83K.
- BRIACELL THERAPEUTICS CORP. unrealized gain (loss) on investments for the quarter ending 2025-10-31 was $89.49K.
- BRIACELL THERAPEUTICS CORP. unrealized gain (loss) on investments for fiscal 2025 was $56.47K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|
| 2026-04-30 | $137.83K 10-Q · filed 2026-06-09 | $137.83K 10-Q · filed 2026-06-09 | |
| 2025-10-31 | $89.49K 10-Q · filed 2025-12-11 | ||
| 2025-07-31 | $56.47K 10-K · filed 2025-10-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |